A private investor group led by Chris Brengard and the US Renal management team, along with Bain Capital Private Equity, Summit Partners, Revelstoke Capital Partners, and Mark Caputo have acquired US Renal Care, a leading provider of dialysis services for patients suffering from end-stage renal disease. Financial terms were not disclosed. US Renal Care partners with nephrologists and hospitals to develop, acquire, and operate outpatient treatment centres for patients suffering from kidney failure, also known as end-stage renal disease. The company provides patients with their choice of a full range of quality in-centre and at-home dialysis. “With additional support and resources, we and our physician partners look forward to embarking on our next phase of growth while continuing to deliver excellent patient outcomes and the best service available in our communities.” Chris Brengard, US Renal Care Chief Executive Officer.